284 related articles for article (PubMed ID: 25544473)
1. Acute effects of viral respiratory tract infections on sputum bacterial density during CF pulmonary exacerbations.
Chin M; De Zoysa M; Slinger R; Gaudet E; Vandemheen KL; Chan F; Hyde L; Mah TF; Ferris W; Mallick R; Aaron SD
J Cyst Fibros; 2015 Jul; 14(4):482-9. PubMed ID: 25544473
[TBL] [Abstract][Full Text] [Related]
2. Reduction in Pseudomonas aeruginosa sputum density during a cystic fibrosis pulmonary exacerbation does not predict clinical response.
Lam JC; Somayaji R; Surette MG; Rabin HR; Parkins MD
BMC Infect Dis; 2015 Mar; 15():145. PubMed ID: 25887462
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic perturbation of mixed-strain Pseudomonas aeruginosa infection in patients with cystic fibrosis.
Tai AS; Sherrard LJ; Kidd TJ; Ramsay KA; Buckley C; Syrmis M; Grimwood K; Bell SC; Whiley DM
BMC Pulm Med; 2017 Nov; 17(1):138. PubMed ID: 29096618
[TBL] [Abstract][Full Text] [Related]
4. 2-Alkyl-4-quinolone quorum sensing molecules are biomarkers for culture-independent
Zain NMM; Webb K; Stewart I; Halliday N; Barrett DA; Nash EF; Whitehouse JL; Honeybourne D; Smyth AR; Forrester DL; Knox AJ; Williams P; Fogarty A; Cámara M; Bruce KD; Barr HL
J Med Microbiol; 2021 Oct; 70(10):. PubMed ID: 34596013
[No Abstract] [Full Text] [Related]
5. Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis.
Reid DW; Carroll V; O'May C; Champion A; Kirov SM
Eur Respir J; 2007 Aug; 30(2):286-92. PubMed ID: 17504792
[TBL] [Abstract][Full Text] [Related]
6. Adult cystic fibrosis: association of acute pulmonary exacerbations and increasing severity of lung disease with auxotrophic mutants of Pseudomonas aeruginosa.
Taylor RF; Hodson ME; Pitt TL
Thorax; 1993 Oct; 48(10):1002-5. PubMed ID: 8256228
[TBL] [Abstract][Full Text] [Related]
7. Does bacterial density in cystic fibrosis sputum increase prior to pulmonary exacerbation?
Stressmann FA; Rogers GB; Marsh P; Lilley AK; Daniels TW; Carroll MP; Hoffman LR; Jones G; Allen CE; Patel N; Forbes B; Tuck A; Bruce KD
J Cyst Fibros; 2011 Sep; 10(5):357-65. PubMed ID: 21664196
[TBL] [Abstract][Full Text] [Related]
8. Pseudomonas-infected cystic fibrosis patient sputum inhibits the bactericidal activity of normal human serum.
Schiller NL; Millard RL
Pediatr Res; 1983 Sep; 17(9):747-52. PubMed ID: 6413945
[TBL] [Abstract][Full Text] [Related]
9. Application of quantitative PCR to the diagnosis and monitoring of Pseudomonas aeruginosa colonization in 5-18-year-old cystic fibrosis patients.
Billard-Pomares T; Herwegh S; Wizla-Derambure N; Turck D; Courcol R; Husson MO
J Med Microbiol; 2011 Feb; 60(Pt 2):157-161. PubMed ID: 20947668
[TBL] [Abstract][Full Text] [Related]
10. Host inflammatory responses to first isolation of Pseudomonas aeruginosa from sputum in cystic fibrosis.
Elborn JS; Cordon SM; Shale DJ
Pediatr Pulmonol; 1993 May; 15(5):287-91. PubMed ID: 8327287
[TBL] [Abstract][Full Text] [Related]
11. Nebulized tobramycin in the treatment of adult CF pulmonary exacerbations.
Al-Aloul M; Nazareth D; Walshaw M
J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):299-305. PubMed ID: 24219814
[TBL] [Abstract][Full Text] [Related]
12. Clinical Isolates of Pseudomonas aeruginosa from Chronically Infected Cystic Fibrosis Patients Fail To Activate the Inflammasome during Both Stable Infection and Pulmonary Exacerbation.
Huus KE; Joseph J; Zhang L; Wong A; Aaron SD; Mah TF; Sad S
J Immunol; 2016 Apr; 196(7):3097-108. PubMed ID: 26895832
[TBL] [Abstract][Full Text] [Related]
13. Utilization of human respiratory secretions by mucoid Pseudomonas aeruginosa of cystic fibrosis origin.
Ohman DE; Chakrabarty AM
Infect Immun; 1982 Aug; 37(2):662-9. PubMed ID: 6811437
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary infection in cystic fibrosis.
Friend PA
J Infect; 1986 Jul; 13(1):55-72. PubMed ID: 3090153
[No Abstract] [Full Text] [Related]
15. Mixed morphotype susceptibility testing of Pseudomonas aeruginosa from patients with cystic fibrosis.
Dunne WM; Chusid MJ
Diagn Microbiol Infect Dis; 1987 Feb; 6(2):165-70. PubMed ID: 3102157
[TBL] [Abstract][Full Text] [Related]
16. Probiotic supplementation affects pulmonary exacerbations in patients with cystic fibrosis: a pilot study.
Weiss B; Bujanover Y; Yahav Y; Vilozni D; Fireman E; Efrati O
Pediatr Pulmonol; 2010 Jun; 45(6):536-40. PubMed ID: 20503277
[TBL] [Abstract][Full Text] [Related]
17. [Respiratory pathogen spectrum in pulmonary exacerbation of bronchiectasis in adults and its association with disease severity].
Gao YH; Guan WJ; Zhu YN; Chen RC; Zhang GJ
Zhonghua Jie He He Hu Xi Za Zhi; 2019 Apr; 42(4):254-261. PubMed ID: 30955282
[No Abstract] [Full Text] [Related]
18. Pulmonary exacerbations in cystic fibrosis with negative bacterial cultures.
Zemanick ET; Wagner BD; Harris JK; Wagener JS; Accurso FJ; Sagel SD
Pediatr Pulmonol; 2010 Jun; 45(6):569-77. PubMed ID: 20503282
[TBL] [Abstract][Full Text] [Related]
19. PCR-based assay for differentiation of Pseudomonas aeruginosa from other Pseudomonas species recovered from cystic fibrosis patients.
Spilker T; Coenye T; Vandamme P; LiPuma JJ
J Clin Microbiol; 2004 May; 42(5):2074-9. PubMed ID: 15131172
[TBL] [Abstract][Full Text] [Related]
20. Lessons from a French collaborative case-control study in cystic fibrosis patients during the 2009 A/H1N1 influenza pandemy.
Bucher J; Boelle PY; Hubert D; Lebourgeois M; Stremler N; Durieu I; Bremont F; Deneuville E; Delaisi B; Corvol H; Bassinet L; Grenet D; Remus N; Vodoff MV; Boussaud V; Troussier F; Leruez-Ville M; Treluyer JM; Launay O; Sermet-Gaudelus I
BMC Infect Dis; 2016 Feb; 16():55. PubMed ID: 26830335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
